Highlights

  • Simble reported further progress in the development of its exclusively licensed NanoSensor Technology.
  • Initial outcomes from the most advanced application areas are expected in the near term.
  • The NanoSensor platform is being evaluated against markets including Industrial IoT, defence sensing and wearable medical devices.
  • Simble is integrating NanoSensor capabilities with its existing SimbleSense and CarbonView platforms.
  • A structured five-stage development framework is being used to assess commercial viability across multiple application pathways.

Simble Solutions Ltd (ASX:SIS) has provided an update on the development of its exclusively licensed NanoSensor Technology, outlining progress across several potential commercial applications and indicating that initial assessment outcomes are expected in the near future. The company said its structured development program has advanced substantially, supported by laboratory data, working prototype devices and technical characterisation work accumulated over multiple years.

During the morning session on 10 June 2026, Simble shares were trading unchanged at AUD 0.007. While the stock showed little movement on the day, the company’s latest update focused on the advancement of its NanoSensor platform and its evaluation across a range of potential commercial markets.

About Simble Solutions

Simble Solutions is a technology company operating across energy efficiency, sustainability and renewable energy sectors. Through its software and hardware platforms, the company provides tools designed to help businesses monitor energy usage, manage sustainability reporting and support emissions reduction initiatives.

Following the Acquisition of exclusive rights to NanoSensor Technology through the Next Nano transaction completed in December 2025, Simble has expanded its technology portfolio into advanced sensing applications. The company now holds the exclusive global commercialisation licence through its Wholly Owned Subsidiary, Next Nano Pty Ltd.

Development Program Nears Initial Milestones

According to the company, the NanoSensor development program has reached an advanced stage, with initial findings from several application areas approaching completion.

The technology was acquired with an existing foundation of laboratory testing, prototype devices and characterisation work developed over a number of years. Simble's current focus has been on assessing where the technology may offer the strongest commercial opportunities and determining which pathways Warrant further development.

Management stated that work across the most advanced application categories is nearing completion, with outcomes expected to be reported as they become available.

Rather than focusing on a single end market, the company has adopted a broad evaluation strategy designed to compare multiple opportunities and identify those that offer the most attractive commercial prospects.

Multiple Commercial Applications Under Evaluation

A significant aspect of the program involves assessing the NanoSensor platform across several distinct application areas.

The company disclosed that current investigations include gas detection systems, ultraviolet and wavelength sensing technologies, electronic skin applications, flexible electronics, multi-sensor integration opportunities and applications relevant to defence and security sectors.

Each of these areas is being evaluated separately, with the objective of identifying commercial pathways that can justify accelerated development and future deployment.

According to Simble, every application category represents an individual commercial opportunity and may require different validation, development and market-entry strategies.

The company noted that these evaluations are designed to determine where the platform can deliver the most value while leveraging its technical characteristics.

Targeting Large and Growing End Markets

Simble highlighted the scale of the industries being assessed as part of the NanoSensor commercialisation strategy.

One area of focus is the Industrial Internet of Things (Industrial IoT) sector, which the company referenced as a market projected to reach approximately US$1.69 trillion by 2030.

The company is also evaluating opportunities linked to chemical, biological, radiological, nuclear and explosive (CBRNe) defence sensing applications, a market referenced as being projected to reach approximately US$30 billion by 2033.

A further area of interest involves wearable medical devices, where the company cited market projections of approximately US$139 billion by 2035.

Management believes these sectors present opportunities for advanced sensing technologies due to the limitations associated with conventional sensor hardware.

What Makes the NanoSensor Platform Different?

According to Simble, the NanoSensor platform is designed around four key characteristics that are rarely combined within a single sensing technology.

These include molecular-level sensitivity, ultra-small form factors, low power requirements and flexibility for integration into a variety of hardware systems.

The company stated that conventional sensors often face limitations relating to size, sensitivity and power consumption. By contrast, NanoSensor technology is being evaluated for its ability to detect extremely small concentrations, operate in compact environments and function with lower energy requirements.

These characteristics are central to the company's assessment process and underpin the commercial opportunities currently under review.

Management emphasised that validation remains application-specific and that ongoing testing is intended to determine where these characteristics translate into commercial advantages.

Structured Evaluation Framework Guides Development

To manage the assessment process, Simble has established a structured five-stage development framework.

The framework is designed to provide consistency across application areas while enabling management to evaluate technical performance, commercial viability and potential customer Demand.

The company indicated that the process extends from initial sensor fabrication through to potential customer trial stages, creating defined decision points throughout the development pathway.

Management believes this approach provides transparency regarding progress and allows shareholders to better understand how different application opportunities are being assessed.

The framework also assists in allocating development resources toward opportunities that demonstrate the greatest commercial potential.

Integration Opportunities Across Existing Platforms

Alongside technical assessments, Simble's engineering and product teams are evaluating how NanoSensor capabilities could be incorporated into the company's existing software platforms.

The company reported that work is underway to determine how SimbleSense and CarbonView can receive, process, visualise and report data generated by future NanoSensor applications.

This work is being conducted in parallel with the technology evaluation program to help shorten the timeline between commercialisation decisions and the deployment of customer-ready solutions.

Management indicated that this integrated development approach could improve efficiency should one or more application areas advance beyond the assessment stage.

Potential Pathway Toward Vertical Integration

The company also outlined how successful commercialisation of NanoSensor applications could create opportunities for vertical integration.

According to Simble, future commercial success may provide a pathway toward Simble-branded sensor devices that integrate both hardware and software capabilities.

Such an approach could allow the company to expand beyond software-based solutions and potentially improve product Economics through ownership of a greater portion of the technology stack.

Management noted that these opportunities remain dependent on the outcomes of the current development program and subsequent commercial assessments.

Building on Existing Technology Foundations

The company emphasised that the current development program is not being undertaken from a standing start.

The NanoSensor platform was acquired with substantial supporting intellectual property, laboratory testing, prototype devices and technical characterisation work already completed.

This existing body of work has allowed Simble to focus on commercial assessment and application evaluation rather than foundational technology development.

The company stated that this positions it to progress more quickly through the commercial evaluation process compared with technologies that remain in early-stage research phases.

Management Focused on Commercial Assessment

Chief Executive Officer Fadi Geha said the company's objective is to determine where the NanoSensor technology can generate the greatest value.

Management noted that the evaluation process is designed to investigate multiple application areas systematically rather than pre-selecting a single commercial pathway.

According to the company, future updates will provide shareholders with visibility over how the technology progresses through the development framework and which opportunities emerge as priorities.

The current focus remains on gathering evidence, validating commercial potential and identifying the pathways that may justify accelerated development.

What This Means for Investors

Simble's latest update highlights continued progress in evaluating the commercial potential of its exclusively licensed NanoSensor Technology. The company is assessing opportunities across multiple sectors including Industrial IoT, defence sensing, healthcare and flexible electronics while advancing a structured development framework designed to identify the most commercially attractive pathways. With initial outcomes from several application areas expected in the near term, investors are likely to monitor future updates as the company progresses its commercial assessment process.